Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Down 11.8% in August

Heart Test Laboratories, Inc. (NASDAQ:HSCSGet Free Report) saw a large decrease in short interest in August. As of August 31st, there was short interest totalling 39,700 shares, a decrease of 11.8% from the August 15th total of 45,000 shares. Approximately 5.5% of the company’s shares are sold short. Based on an average daily volume of 57,900 shares, the short-interest ratio is presently 0.7 days.

Heart Test Laboratories Trading Down 2.4 %

NASDAQ HSCS traded down $0.07 during trading hours on Wednesday, hitting $2.81. 16,061 shares of the company’s stock were exchanged, compared to its average volume of 57,723. The firm has a market cap of $1.84 million, a price-to-earnings ratio of -0.06 and a beta of 3.13. The stock has a 50-day simple moving average of $3.47 and a 200 day simple moving average of $6.82. Heart Test Laboratories has a 1-year low of $2.36 and a 1-year high of $75.47.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

Read More

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.